Showing results (1051-1060 of 1,411) with videos related to

Sort By:
Pageof 142
NPJ Parkinson'S Disease|September 25, 2021
Optimising classification of Parkinson's disease based on motor, olfactory, neuropsychiatric and sleep featuresJonathan P Bestwick, Stephen D Auger, Anette E Schrag, et al.
NPJ Parkinson'S Disease|October 9, 2021
Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's diseaseHua-Ying Cai, Xiao-Xiao Fu, Hong Jiang, et al.
NPJ Parkinson'S Disease|February 12, 2022
High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson's diseaseNasia Antoniou, Kanella Prodromidou, Georgia Kouroupi, et al.
NPJ Parkinson'S Disease|July 3, 2019
Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson's diseaseJosefine Waldthaler, Panagiota Tsitsi, Per Svenningsson
NPJ Parkinson'S Disease|March 16, 2022
Restricted truncal sagittal movements of rapid eye movement behaviour disorderDanielle Wasserman, Silvia Gullone, Iain Duncan, et al.
NPJ Parkinson'S Disease|April 23, 2022
Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modelingXuyang Wang, Kwangsun Yoo, Huafu Chen, et al.
NPJ Parkinson'S Disease|April 28, 2022
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced ParkinsonismWhitley W Aamodt, Jacob G Dubroff, Gang Cheng, et al.
NPJ Parkinson'S Disease|March 19, 2022
Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's diseaseRobert A Hauser, Judy Lytle, Andrea E Formella, et al.
NPJ Parkinson'S Disease|April 14, 2022
Self-reported periodontitis and C-reactive protein in Parkinson's disease: a cross-sectional study of two American cohortsPatrícia Lyra, João Botelho, Vanessa Machado, et al.
NPJ Parkinson'S Disease|April 14, 2022
Basal ganglia neuropeptides show abnormal processing associated with L-DOPA-induced dyskinesiaHeather Hulme, Elva Fridjonsdottir, Theodosia Vallianatou, et al.
Pageof 142